# Service Corp International: financial statements, quarterly

SCI · NYSE · CIK 89089 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sci.md) · [Financials](/companies/sci/financials.md) · [Filings](/companies/sci/filings.md) · [Insiders](/companies/sci/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sci/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,056 d](/filings/0001628280-26-007695.md) | [1,045](/filings/0000089089-25-000058.md) | [1,034](/filings/0001628280-25-036985.md) | [1,014](/filings/0000089089-25-000083.md) | [1,093 d](/filings/0001628280-26-007695.md) | [1,074](/filings/0000089089-26-000034.md) | [1,065](/filings/0000089089-26-000081.md) | [1,058](/filings/0000089089-26-000098.md) | [1,112 d](/filings/0001628280-26-007695.md) | [1,096](/filings/0000089089-26-000034.md) | [1,103](/filings/0000089089-26-000081.md) | [1,107](/filings/0000089089-26-000098.md) |
| Cost of revenue | $m | [768 d](/filings/0001628280-26-007695.md) | [771](/filings/0000089089-25-000058.md) | [776](/filings/0001628280-25-036985.md) | [761](/filings/0000089089-25-000083.md) | [787 d](/filings/0001628280-26-007695.md) | [783](/filings/0000089089-26-000034.md) | [794](/filings/0000089089-26-000081.md) | [793](/filings/0000089089-26-000098.md) | [800 d](/filings/0001628280-26-007695.md) | [810](/filings/0000089089-26-000034.md) | [830](/filings/0000089089-26-000081.md) | [835](/filings/0000089089-26-000098.md) |
| Gross profit | $m | [288 d](/filings/0001628280-26-007695.md) | [274](/filings/0000089089-25-000058.md) | [258](/filings/0001628280-25-036985.md) | [253](/filings/0000089089-25-000083.md) | [306 d](/filings/0001628280-26-007695.md) | [291](/filings/0000089089-26-000034.md) | [271](/filings/0000089089-26-000081.md) | [266](/filings/0000089089-26-000098.md) | [312 d](/filings/0001628280-26-007695.md) | [286](/filings/0000089089-26-000034.md) | [274](/filings/0000089089-26-000081.md) | [272](/filings/0000089089-26-000098.md) |
| Operating income | $m | [242 d](/filings/0001628280-26-007695.md) | [232](/filings/0000089089-25-000058.md) | [221](/filings/0001628280-25-036985.md) | [212](/filings/0000089089-25-000083.md) | [262 d](/filings/0001628280-26-007695.md) | [252](/filings/0000089089-26-000034.md) | [224](/filings/0000089089-26-000081.md) | [226](/filings/0000089089-26-000098.md) | [276 d](/filings/0001628280-26-007695.md) | [244](/filings/0000089089-26-000034.md) | [232](/filings/0000089089-26-000081.md) | [253](/filings/0000089089-26-000098.md) |
| Interest expense | $m | [64.5 d](/filings/0001628280-26-007695.md) | [64.4](/filings/0000089089-25-000058.md) | [64.4](/filings/0001628280-25-036985.md) | [65.8](/filings/0000089089-25-000083.md) | [63.2 d](/filings/0001628280-26-007695.md) | [61.5](/filings/0000089089-26-000034.md) | [64.1](/filings/0000089089-26-000081.md) | [65.7](/filings/0000089089-26-000098.md) | [64.1 d](/filings/0001628280-26-007695.md) | [64.0](/filings/0000089089-26-000034.md) | [64.7](/filings/0000089089-26-000081.md) | [65.0](/filings/0000089089-26-000098.md) |
| Income tax | $m | [41.4 d](/filings/0001628280-26-007695.md) | [39.0](/filings/0000089089-25-000058.md) | [40.0](/filings/0001628280-25-036985.md) | [31.5](/filings/0000089089-25-000083.md) | [46.1 d](/filings/0001628280-26-007695.md) | [50.4](/filings/0000089089-26-000034.md) | [41.4](/filings/0000089089-26-000081.md) | [43.3](/filings/0000089089-26-000098.md) | [51.8 d](/filings/0001628280-26-007695.md) | [45.3](/filings/0000089089-26-000034.md) | [41.9](/filings/0000089089-26-000081.md) | [47.5](/filings/0000089089-26-000098.md) |
| Net income | $m | [138 d](/filings/0001628280-26-007695.md) | [131](/filings/0000089089-25-000058.md) | [118](/filings/0001628280-25-036985.md) | [118](/filings/0000089089-25-000083.md) | [151 d](/filings/0001628280-26-007695.md) | [143](/filings/0000089089-26-000034.md) | [123](/filings/0000089089-26-000081.md) | [117](/filings/0000089089-26-000098.md) | [159 d](/filings/0001628280-26-007695.md) | [136](/filings/0000089089-26-000034.md) | [125](/filings/0000089089-26-000081.md) | [141](/filings/0000089089-26-000098.md) |
| Diluted EPS | $ per share | not reported | [0.89](/filings/0000089089-25-000058.md) | [0.81](/filings/0001628280-25-036985.md) | [0.81](/filings/0000089089-25-000083.md) | not reported | [0.98](/filings/0000089089-26-000034.md) | [0.86](/filings/0000089089-26-000081.md) | [0.83](/filings/0000089089-26-000098.md) | not reported | [0.97](/filings/0000089089-26-000034.md) | [0.90](/filings/0000089089-26-000081.md) | [1.03](/filings/0000089089-26-000098.md) |
| Basic EPS | $ per share | not reported | [0.90](/filings/0000089089-25-000058.md) | [0.81](/filings/0001628280-25-036985.md) | [0.81](/filings/0000089089-25-000083.md) | not reported | [0.99](/filings/0000089089-26-000034.md) | [0.87](/filings/0000089089-26-000081.md) | [0.84](/filings/0000089089-26-000098.md) | not reported | [0.98](/filings/0000089089-26-000034.md) | [0.91](/filings/0000089089-26-000081.md) | [1.04](/filings/0000089089-26-000098.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000089089-25-000011.md) | [0.2](/filings/0000089089-24-000093.md) | [0.2](/filings/0000089089-24-000137.md) | [0.2](/filings/0000089089-24-000175.md) | [0.2](/filings/0001628280-26-007695.md) | [0.2](/filings/0000089089-25-000058.md) | [0.3](/filings/0001628280-25-036985.md) | [0.2](/filings/0000089089-25-000083.md) | [0.2](/filings/0000089089-26-000098.md) | [0.3](/filings/0000089089-26-000034.md) | [0.3](/filings/0000089089-26-000081.md) | [0.2](/filings/0000089089-26-000098.md) |
| Current assets | $bn | [0.5](/filings/0000089089-25-000011.md) | [0.4](/filings/0000089089-24-000093.md) | [0.4](/filings/0000089089-24-000137.md) | [0.4](/filings/0000089089-24-000175.md) | [0.4](/filings/0001628280-26-007695.md) | [0.4](/filings/0000089089-25-000058.md) | [0.4](/filings/0001628280-25-036985.md) | [0.4](/filings/0000089089-25-000083.md) | [0.4](/filings/0000089089-26-000098.md) | [0.4](/filings/0000089089-26-000034.md) | [0.4](/filings/0000089089-26-000081.md) | [0.4](/filings/0000089089-26-000098.md) |
| Total assets | $bn | [16.4](/filings/0000089089-25-000011.md) | [16.7](/filings/0000089089-24-000093.md) | [16.8](/filings/0000089089-24-000137.md) | [17.4](/filings/0000089089-24-000175.md) | [17.4](/filings/0001628280-26-007695.md) | [17.3](/filings/0000089089-25-000058.md) | [18.0](/filings/0001628280-25-036985.md) | [18.4](/filings/0000089089-25-000083.md) | [18.7](/filings/0000089089-26-000098.md) | [18.6](/filings/0000089089-26-000034.md) | [19.2](/filings/0000089089-26-000081.md) | [19.1](/filings/0000089089-26-000098.md) |
| Current liabilities | $bn | [0.7](/filings/0000089089-25-000011.md) | [0.7](/filings/0000089089-24-000093.md) | [0.7](/filings/0000089089-24-000137.md) | [0.7](/filings/0000089089-24-000175.md) | [0.7](/filings/0001628280-26-007695.md) | [0.8](/filings/0000089089-25-000058.md) | [0.7](/filings/0001628280-25-036985.md) | [0.8](/filings/0000089089-25-000083.md) | [0.7](/filings/0000089089-26-000098.md) | [0.8](/filings/0000089089-26-000034.md) | [0.8](/filings/0000089089-26-000081.md) | [0.9](/filings/0000089089-26-000098.md) |
| Long-term debt | $bn | [4.6](/filings/0000089089-25-000011.md) | [4.6](/filings/0000089089-24-000093.md) | [4.7](/filings/0000089089-24-000137.md) | [4.8](/filings/0000089089-24-000175.md) | [4.8](/filings/0001628280-26-007695.md) | [4.8](/filings/0000089089-25-000058.md) | [5.0](/filings/0001628280-25-036985.md) | [5.0](/filings/0000089089-25-000083.md) | [5.1](/filings/0000089089-26-000098.md) | [5.1](/filings/0000089089-26-000034.md) | [5.1](/filings/0000089089-26-000081.md) | [5.0](/filings/0000089089-26-000098.md) |
| Current portion of debt | $bn | [0.1](/filings/0000089089-25-000011.md) | [0.1](/filings/0000089089-24-000093.md) | [0.1](/filings/0000089089-24-000137.md) | [0.1](/filings/0000089089-24-000175.md) | [0.1](/filings/0001628280-26-007695.md) | [0.1](/filings/0000089089-25-000058.md) | [0.1](/filings/0001628280-25-036985.md) | [0.1](/filings/0000089089-25-000083.md) | [0.1](/filings/0000089089-26-000098.md) | [0.1](/filings/0000089089-26-000034.md) | [0.2](/filings/0000089089-26-000081.md) | [0.2](/filings/0000089089-26-000098.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.5](/filings/0000089089-25-000011.md) | [1.6](/filings/0000089089-24-000093.md) | [1.5](/filings/0000089089-24-000137.md) | [1.6](/filings/0000089089-24-000175.md) | [1.7](/filings/0001628280-26-007695.md) | [1.7](/filings/0000089089-25-000058.md) | [1.6](/filings/0001628280-25-036985.md) | [1.6](/filings/0000089089-25-000083.md) | [1.6](/filings/0000089089-26-000098.md) | [1.6](/filings/0000089089-26-000034.md) | [1.5](/filings/0000089089-26-000081.md) | [1.6](/filings/0000089089-26-000098.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [278 d](/filings/0001628280-26-007695.md) | [220](/filings/0000089089-25-000058.md) | [197 d](/filings/0001628280-25-036985.md) | [264 d](/filings/0000089089-25-000083.md) | [264 d](/filings/0001628280-26-007695.md) | [311](/filings/0000089089-26-000034.md) | [166 d](/filings/0000089089-26-000081.md) | [252 d](/filings/0000089089-26-000098.md) | [213 d](/filings/0001628280-26-007695.md) | [334](/filings/0000089089-26-000034.md) | [239 d](/filings/0000089089-26-000081.md) | [297 d](/filings/0000089089-26-000098.md) |
| Capital expenditure | $m | [94.0 d](/filings/0001628280-26-007695.md) | [79.3](/filings/0000089089-25-000058.md) | [91.7 d](/filings/0001628280-25-036985.md) | [96.5 d](/filings/0000089089-25-000083.md) | [106 d](/filings/0001628280-26-007695.md) | [78.2](/filings/0000089089-26-000034.md) | [83.0 d](/filings/0000089089-26-000081.md) | [102 d](/filings/0000089089-26-000098.md) | [126 d](/filings/0001628280-26-007695.md) | [79.9](/filings/0000089089-26-000034.md) | [95.7 d](/filings/0000089089-26-000081.md) | [99.5 d](/filings/0000089089-26-000098.md) |
| Dividends paid | $m | [42.4 d](/filings/0001628280-26-007695.md) | [43.9](/filings/0000089089-25-000058.md) | [43.4 d](/filings/0001628280-25-036985.md) | [43.5 d](/filings/0000089089-25-000083.md) | [43.5 d](/filings/0001628280-26-007695.md) | [46.0](/filings/0000089089-26-000034.md) | [45.1 d](/filings/0000089089-26-000081.md) | [44.8 d](/filings/0000089089-26-000098.md) | [47.6 d](/filings/0001628280-26-007695.md) | [47.1](/filings/0000089089-26-000034.md) | [49.3 d](/filings/0000089089-26-000081.md) | [49.1 d](/filings/0000089089-26-000098.md) |
| Share repurchases | $m | [205 d](/filings/0001628280-26-007695.md) | [49.5](/filings/0000089089-25-000058.md) | [127 d](/filings/0001628280-25-036985.md) | [21.1 d](/filings/0000089089-25-000083.md) | [56.2 d](/filings/0001628280-26-007695.md) | [130](/filings/0000089089-26-000034.md) | [194 d](/filings/0000089089-26-000081.md) | [78.1 d](/filings/0000089089-26-000098.md) | [58.9 d](/filings/0001628280-26-007695.md) | [143](/filings/0000089089-26-000034.md) | [123 d](/filings/0000089089-26-000081.md) | [52.6 d](/filings/0000089089-26-000098.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q1 FY2023 (2023-06-30) | Q1 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [155](/filings/0000089089-24-000093.md) | [153](/filings/0000089089-24-000137.md) | [152](/filings/0000089089-24-000175.md) | [148](/filings/0000089089-25-000058.md) | [147](/filings/0001628280-25-036985.md) | [146](/filings/0000089089-25-000083.md) | [145](/filings/0000089089-26-000034.md) | [143](/filings/0000089089-26-000081.md) | [141](/filings/0000089089-26-000098.md) | [140](/filings/0000089089-26-000034.md) | [138](/filings/0000089089-26-000081.md) | [137](/filings/0000089089-26-000098.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 136,149,458 at 2026-09-30, from the cover of the [10-Q filed 2026-10-29](/filings/0000089089-26-000098.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 14:07 ET. No prices; not investment advice.